Endocrinology
- Newer diabetes drugs: Surprising shared benefits and unique side effects
The shared beneficial effects of the SGLT2 inhibitors and the GLP-1 receptor agonists, drugs with distinct mechanisms of action, may have an anti-inflammatory explanation.
- The overlooked and undertreated perils of premature ovarian insufficiency
Physicians should be alert to the possibility of undiagnosed premature ovarian insufficiency—loss of ovarian function before age 40—and know what to do if the condition is suspected.
- Glucagon-like peptide-1 receptor agonists and pancreatitis: A reconcilable divorce
Early trials suggested a link between GLP-1 receptor agonists and pancreatitis, but recent large meta-analyses do not support a class-wide risk.
- Managing the side effects of sodium-glucose cotransporter-2 inhibitors
The authors review recent evidence on the side effects of sodium-glucose cotransporter-2 inhibitors and corresponding strategies for preventing and managing them.
- Managing noninsulin glucose-lowering medications before surgery: A comparison of clinical practice guidelines
Recommendations for adjusting the treatment regimen of each class of noninsulin glucose-lowering agents before surgery are discussed.